1. ScholarBank@NUS

Wei Peng Yong

rp05452

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wei Peng Yong
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
Main Affiliation
 
Faculty
 
Email
csiywp@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2010 TO 2020]

Results 41-56 of 56 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
411-Oct-2011Recent progress and clinical importance on pharmacogenetics in cancer therapySoh, T.I.P.; Yong, W.P. ; Innocenti, F.
421-May-2018Resisting resistance to cancer immunotherapyRAGHAV SUNDAR; Lam, W.S.-T.; Wang, L.Z.; Roudi, R.; Yong, W.-P. ; Syn, N.L.
4323-Aug-2011Sequential expression of putative stem cell markers in gastric carcinogenesisWang, T. ; Ong, C.W. ; Shi, J. ; Srivastava, S. ; Yan, B.; Cheng, C.L.; Yong, W.P. ; Chan, S.L.; Yeoh, K.G.; Iacopetta, B.; Salto-Tellez, M. 
442014SPHK1 regulates proliferation and survival responses in triplenegative breast cancerDatta, A ; Loo, S.Y ; Huang, B ; Wong, L ; Tan, S.S.L ; Tan, T.Z ; Lee, S.-C ; Thiery, J.P ; Lim, Y.C ; Yong, W.P ; Lam, Y ; Kumar, A.P ; Yap, C.T 
452015Strategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapySubhash, V.V; Yeo, M.S; Tan, W.L; Yong, W.P 
462018Study protocol: Phase 1 dose escalating study of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasisKim, G.; Tan, H.L.; Chen, E.; Teo, S.C. ; Jang, C.J.M. ; Ho, J. ; Ang, Y.; Ngoi, N.Y.L. ; Chee, C.E.; Lieske, B.; Shabbir, A.; Wang, L.-Z.; So, J.B.Y. ; Yong, W.P. 
47Jun-2012Systemic therapies for pancreatic cancer - the role of pharmacogeneticsSoo, R.A. ; Yong, W.-P. ; Innocenti, F.
48May-2012Tamoxifen-induced eccrine squamous syringometaplasiaTeoh, D.C.-W.; Aw, D.C.-W.; Jaffar, H.; Ling, W.; Yong, W.-P. ; Lee, Y.-S.; Choo, S.-N.; Tan, K.-B.
4915-Dec-2013The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancerMimura, K.; Shiraishi, K.; Mueller, A.; Izawa, S.; Kua, L.-F.; So, J.; Yong, W.-P. ; Fujii, H.; Seliger, B.; Kiessling, R.; Kono, K.
50Feb-2014The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancersSubramaniam, M.M. ; Loh, M.; Chan, J.Y.; Liem, N.; Lim, P.L.; Peng, Y.W. ; Lim, X.Y. ; Yeoh, K.G.; Iacopetta, B.; Soong, R.; Salto-Tellez, M. 
512015Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenibWong A.L.A. ; Lim J.S.J. ; Sinha A. ; Gopinathan A. ; Lim R.; Tan C.-S. ; Soh T.; Venkatesh S.; Titin C.; Sapari N.S. ; Lee S.-C. ; Yong W.-P. ; Tan D.S.P. ; Pang B. ; Wang T.-T. ; Zee Y.-K.; Soong R. ; Trnkova Z.; Lathia C.; Thiery J.-P.; Wilhelm S.; Jeffers M.; Goh B.-C. 
5217-Aug-2012UGT1A6 polymorphisms modulated lung cancer risk in a Chinese populationKua, L.-F.; Ross, S. ; Lee, S.-C. ; Mimura, K.; Kono, K.; Goh, B.-C.; Yong, W.-P. 
53Sep-2010Upregulation of plasma C9 protein in gastric cancer patientsChong, P.-K.; Lee, H.; Loh, M.C.S.; Choong, L.-Y.; Lin, Q. ; So, J.B.Y.; Lim, K.H.; Soo, R.A. ; Yong, W.P. ; Chan, S.P.; Smoot, D.T.; Ashktorab, H.; Yeoh, K.G.; Lim, Y.P. 
542012Validation of the functional assessment of cancer therapy-gastric module for the Chinese populationZhou H.J. ; So J.B. ; Yong W.P. ; Luo N. ; Zhu F. ; Naidoo N.; Li S.C.; Yeoh K.G. 
552018Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyHeong V.; Syn N.L.; Lee X.W.; Sapari N.S. ; Koh X.Q.; Adam Isa Z.F. ; Sy Lim J.; Lim D. ; Pang B. ; Thian Y.L. ; Ng L.K. ; Wong A.L. ; Soo R.A. ; Yong W.P. ; Chee C.E. ; Lee S.-C., Goh B.-C. ; Soong R. ; Tan D.S.P. 
562020Whole exome sequencing of multi-regional biopsies from metastatic lesions to evaluate actionable truncal mutations using a single-pass percutaneous techniqueHeong V.; Tay D.; Goh S.E. ; Wee B. ; Tan T.Z. ; Soo R. ; Pang B. ; Lim D. ; Gopinathan A. ; Ow S. ; Chee C.E. ; Goh B.C. ; Lee S.C. ; Yong W.P. ; Wong A. ; Omar M.F.M. ; Soong R. ; Tan D.S.P.